Fidia Issues 5 Million New Shares After Partial Convertible Bond Conversion

Fidia Spa ( (IT:FDA) ) has provided an update.

Fidia S.p.A., headquartered in Turin and listed on Euronext Milan, is a long-established specialist in high-performance milling technology for complex shapes, particularly for automotive moulds and aerospace applications. The group provides integrated numerical controls, high-speed milling systems and CAM software, positioning itself as a full-process solutions provider in an advanced manufacturing niche.

The company disclosed that Global Growth Holding Limited has converted five bonds from the fifth tranche of Fidia’s reserved convertible bond loan into 5,000,000 new shares at a price of €0.01 per share. Following this partial conversion, Fidia’s share capital rises by €50,000 to about €10.97 million, bringing the total number of shares outstanding to 71,542,927, while 13 bonds in the same tranche remain subscribed but unconverted.

The most recent analyst rating on (IT:FDA) stock is a Sell with a EUR0.11 price target. To see the full list of analyst forecasts on Fidia Spa stock, see the IT:FDA Stock Forecast page.

More about Fidia Spa

Fidia S.p.A., based in Turin and listed on Euronext Milan, is a global player in high-performance integrated milling systems, serving primarily the automotive mould-making and aerospace sectors. With over five decades of experience and around 135 employees, the group offers end-to-end solutions across the milling process, including numerical controls, high-speed milling machines and CAM software for complex shapes.

The company differentiates itself as one of the few industrial providers able to cover the full workflow from machining program definition to the finished product, supporting customers worldwide with hardware, software and after-sales services. This integrated offering underpins Fidia’s competitive position in niche, technology-intensive segments of the manufacturing equipment market.

Average Trading Volume: 1,831,555

Technical Sentiment Signal: Strong Sell

Current Market Cap: €472.5K

For a thorough assessment of FDA stock, go to TipRanks’ Stock Analysis page.